Skip to main content
Georgia Cancer Info Logo
Donate
Georgia Cancer Info Logo
About Georgia CORENews & HappeningsWays to Give
Advancing ResearchExplore Clinical TrialsCollaboration Opportunities
ScreeningGeorgia Genetics ProgramEducation & NavigationSurvivorship

Check your hereditary breast & ovarian cancer risk with our easy Genetic Screening Tool.

Start risk assessment
Search ResourcesFind Cancer Centers
Donate
Georgia Cancer Info Logo

Contact us

+1-404-523-8735info@georgiacancerinfo.org
999 Peachtree St NE, Suite 400Atlanta, GA 30309

Sign up for news and announcements

  • Home
  • About
  • Contact
  • Facebook
  • LinkedIn
  • Instagram

© 2005 - 2026 Georgia Center for Oncology Research and Education. All Rights Reserved.

PrivacyTerms & Conditions
Steven L. McCune, MD, PhD
  1. About Us/
  2. Steven L. McCune, MD, PhD

Steven L. McCune, MD, PhD

Oncology Physician Lead, Northwest Georgia Oncology Centers/Wellstar Health System

Dr. Steve McCune is the physician lead for the oncology service line of the Wellstar Health System. He has been a medical oncologist with Northwest Georgia Oncology since 2003. Dr. McCune earned an MD/PhD at the University of Alabama at Birmingham with a focus on gene therapy and blood substitutes followed by internal medicine residency at UAB. He then completed fellowship training in oncology at Duke University. He served as the principal investigator for clinical trials for Northwest Georgia Oncology from 2016 to 2025. Board-certified in medical oncology and hematology, Dr. McCune is a member of the American Society of Clinical Oncology and a fellow of the Academy of Physicians in Clinical Research.

Steven L. McCune, MD, PhD

Keep up to date with Georgia CORE on LinkedIn

Real stories from patients, survivors, and advocates across Georgia.

Follow on LinkedIn
Oct. stakeholder session: Should Georgia have a cancer clinical trials roundtable?

Day 2 of an impressive convening of Georgia CORE partners representing the cancer research, care provider, patient navigation and advocacy communities. Each stakeholder session was an opportunity for these groups to come together and discuss how to carry the recommendations forward of the Georgia House Study Committee on Access to Cancer Care on day 1; and the state of cancer clinical trials in Georgia on day 2. Be on the look out for the forthcoming report of these impactful two days!